What's new

Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 4, Status: Authorised

Mar 6, 2025 - 11:40
 0
Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Yorvipath, Palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Spring has sprung at Costa Coffee with new menu launching today

Next Article

Pomellato amplifies call to action against domestic violence

Related Posts

Human medicines European public assessment report (EPAR): mResvia, Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation, Date of authorisation: 22/08/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

Webinar on PMS Project Made Easy: Summary of activities and Practical Tips for SMEs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 February 2025, 14:00 (CET) to 24 February 2025, 16:00 (CET)

Webinar on PMS Project Made Easy: Summary of activities...

Feb 11, 2025  0